Advanced search
Publication Cover
Epigenomics Volume 5, 2013 - Issue 5
Submit an article Journal homepage
234
Views
0
CrossRef citations to date
0
Altmetric
Review

Role of Epigenetics in Rett Syndrome

Takeo Kubota1 Department of Epigenetics Medicine, Interdisciplinary Graduate School of Medicine & Engineering, University of Yamanashi, Yamanashi, 1110 Shimokato, Chuo, Yamanashi409-3898, JapanCorrespondence[email protected]
View further author information
,
Kunio Miyake1 Department of Epigenetics Medicine, Interdisciplinary Graduate School of Medicine & Engineering, University of Yamanashi, Yamanashi, 1110 Shimokato, Chuo, Yamanashi409-3898, JapanView further author information
&
Takae Hirasawa1 Department of Epigenetics Medicine, Interdisciplinary Graduate School of Medicine & Engineering, University of Yamanashi, Yamanashi, 1110 Shimokato, Chuo, Yamanashi409-3898, JapanView further author information
Pages 583-592 | Published online: 24 Sep 2013

References

  • Hagberg B , AicardiJ, DiasK, RamosO. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett‘s syndrome: report of 35 cases. Ann. Neurol.14 , 471–479 (1983).
  • Bienvenu T , PhilippeC, De Roux N et al. The incidence of Rett syndrome in France. Pediatr. Neurol.34 , 372–375 (2006).
  • Webb T , ClarkeA, HanefeldF, PereiraJL, RosenbloomL, WoodsCG. Linkage analysis in Rett syndrome families suggests that there may be a critical region at Xq28. J. Med. Genet.35 , 997–1003 (1998).
  • Amir RE , Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet.23 , 185–188 (1999).
  • Kubota T , SaitohS, MatsumotoT et al. Excess functional copy of allele at chromosomal region 11p15 may cause Wiedemann–Beckwith (EMG) syndrome. Am. J. Med. Genet. 49 , 378–383 (1994).
  • Kubota T , DasS, ChristianSL, BaylinSB, HermanJG, LedbetterDH. Methylation-specific PCR simplifies imprinting analysis. Nat. Genet.16 , 16–17 (1997).
  • Kubota T , WakuiK, NakamuraT et al. The proportion of cells with functional X disomy is associated with the severity of mental retardation in mosaic ring X Turner syndrome females. Cytogenet. Genome Res. 99 , 276–284 (2002).
  • Okano M , BellDW, HaberDA, LiE. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell99 , 247–257 (1999).
  • Xu GL , BestorTH, Bourc‘hisD et al. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402 , 187–191 (1999).
  • Shirohzu H , KubotaT, KumazawaA et al. Three novel DNMT3B mutations in Japanese patients with ICF syndrome. Am. J. Med. Genet. 112 , 31–37 (2002).
  • Chunshu Y , EndohK, SoutomeM, KawamuraR, KubotaT. A patient with classic Rett syndrome with a novel mutation in MECP2 exon 1. Clin. Genet.70 , 530–531 (2006).
  • Monteggia LM , KavalaliET. Rett syndrome and the impact of MeCP2 associated transcriptional mechanisms on neurotransmission. Biol. Psychiatry65 , 204–210 (2009).
  • Takeshita E , SaitoY, NakagawaE et al. Late-onset mental deterioration and fluctuating dystonia in a female patient with a truncating MECP2 mutation. J. Neurol. Sci. 308 , 168–172 (2011).
  • Augenstein K , LaneJB, HortonA, SchanenC, PercyAK. Variable phenotypic expression of a MECP2 mutation in a family. J. Neurodev. Disord.1 , 313 (2009).
  • Schanen NC , DahleEJ, CapozzoliF, HolmVA, ZoghbiHY, FranckeU. A new Rett syndrome family consistent with X-linked inheritance expands the X chromosome exclusion map. Am. J. Hum. Genet.61 , 634–641 (1997).
  • Nan X , CampoyFJ, BirdA. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell88 , 471–481 (1997).
  • Kudo S . Methyl-CpG-binding protein MeCP2 represses Sp1-activated transcription of the human leukosialin gene when the promoter is methylated. Mol. Cell. Biol.18 , 5492–5499 (1998).
  • Hendrich B , BirdA. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol.18 , 6538–6547 (1998).
  • Nan X , BirdA. The biological functions of the methyl-CpG-binding protein MeCP2 and its implication in Rett syndrome. Brain Dev.23(Suppl. 1) , S32–S37 (2001).
  • Wolffe AP . Histone deacetylase: a regulator of transcription. Science272 , 371–372 (1996).
  • Jones PL , VeenstraGJ, WadePA et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19 , 187–191 (1998).
  • Fuks F , HurdPJ, WolfD, NanX, BirdAP, KouzaridesT. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem.278 , 4035–4040 (2003).
  • Guy J , HendrichB, HolmesM, MartinJE, BirdA. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet.27 , 322–326 (2001).
  • Chen RZ , AkbarianS, TudorM, JaenischR. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet.27 , 327–331 (2001).
  • Collins AL , LevensonJM, VilaythongAP et al. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum. Mol. Genet. 13 , 2679–2689 (2004).
  • Van Esch H , BautersM, IgnatiusJ et al. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am. J. Hum. Genet. 77 , 442–453 (2005).
  • Chao HT , ZoghbiHY, RosenmundC. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron56 , 58–65 (2007).
  • Yasui DH , PeddadaS, BiedaMC et al. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc. Natl Acad. Sci. USA 104 , 19416–19421 (2007).
  • Chahrour M , JungSY, ShawC et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320 , 1224–1229 (2008).
  • Mellén M , AyataP, DewellS, KriaucionisS, HeintzN. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell151 , 1417–1430 (2012).
  • Gonzales ML , AdamsS, DunawayKW, LaSalleJM. Phosphorylation of distinct sites in MeCP2 modifies cofactor associations and the dynamics of transcriptional regulation. Mol. Cell. Biol.32 , 2894–2903 (2012).
  • Lyst MJ , EkiertR, EbertDH et al. Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor. Nat. Neurosci. 16 , 898–902 (2013).
  • Ebert DH , GabelHW, RobinsonND et al. Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR. Nature 499 , 341–345 (2013).
  • Young JI , HongEP, CastleJC et al. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc. Natl Acad. Sci. USA 102 , 17551–17558 (2005).
  • Ballestar E , YusufzaiTM, WolffeAP. Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA. Biochemistry39 , 7100–7106 (2000).
  • Adkins NL , GeorgelPT. MeCP2: structure and function. Biochem. Cell Biol.89 , 1–11 (2011).
  • Goffin D , AllenM, ZhangL et al. Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses. Nat. Neurosci. 15 , 274–283 (2011).
  • Shahbazian MD , AntalffyB, ArmstrongDL, ZoghbiHY. Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum. Mol. Genet.11 , 115–124 (2002).
  • Nagai K , MiyakeK, KubotaT. A transcriptional repressor MeCP2 causing Rett syndrome is expressed in embryonic non-neuronal cells and controls their growth. Brain Res. Dev. Brain Res.157 , 103–106 (2005).
  • Ballas N , LioyDT, GrunseichC, MandelG. Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat. Neurosci.12 , 311–317 (2009).
  • Maezawa I , SwanbergS, HarveyD, LaSalleJM, JinLW. Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. J. Neurosci.29 , 5051–5061 (2009).
  • Lioy DT , GargSK, MonaghanCE et al. A role for glia in the progression of Rett‘s syndrome. Nature 475 , 497–500 (2011).
  • Derecki NC , CronkJC, LuZ et al. Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 484 , 105–109 (2012).
  • Derecki NC , CronkJC, KipnisJ. The role of microglia in brain maintenance: implications for Rett syndrome. Trends Immunol.34 , 144–150 (2013).
  • Tudor M , AkbarianS, ChenRZ, JaenischR. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc. Natl Acad. Sci. USA99 , 15536–15341 (2002).
  • Chen WG , ChangQ, LinY et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302 , 885–889 (2003).
  • Martinowich K , HattoriD, WuH, FouseS, HeF, HuY. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science302 , 890–893 (2003).
  • Karege F , PerretG, BondolfiG, SchwaldM, BertschyG, AubryJM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res.109 , 143–148 (2002).
  • Thompson Ray M , WeickertCS, WyattE, WebsterMJ. Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. J. Psychiatry Neurosci.36 , 195–203 (2011).
  • Horike S , CaiS, MiyanoM, ChengJF, Kohwi-ShigematsuT. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat. Genet.37 , 31–40 (2005).
  • Peddada S , YasuiDH, LaSalleJM. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome. Hum. Mol. Genet.15 , 2003–2014 (2006).
  • McGill BE , BundleSF, YaylaogluMB, CarsonJP, ThallerC, ZoghbiHY. Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome. Proc. Natl Acad. Sci. USA103 , 18267–18272 (2006).
  • Itoh M , IdeS, TakashimaS et al. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains. J. Neuropathol. Exp. Neurol. 66 , 117–123 (2007).
  • Carouge D , HostL, AunisD, ZwillerJ, AnglardP. CDKL5 is a brain MeCP2 target gene regulated by DNA methylation. Neurobiol. Dis.38 , 414–424 (2010).
  • Miyake K , HirasawaT, SoutomeM et al. The protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues. implication for pathogenesis of Rett syndrome. BMC Neurosci. 12 , 81 (2011).
  • Chao HT , ZoghbiHY, RosenmundC. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron56 , 58–65 (2007).
  • Kaufmann WE , JarrarMH, WangJS et al. Histone modifications in Rett syndrome lymphocytes: a preliminary evaluation. Brain Dev. 27 , 331–339 (2005).
  • Lilja T , WallenborgK, BjörkmanK et al. Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients. Epigenetics 8 , 246–251 (2013).
  • Vecsler M , SimonAJ, AmariglioN, RechaviG, GakE. MeCP2 deficiency downregulates specific nuclear proteins that could be partially recovered by valproic acid in vitro. Epigenetics5 , 61–67 (2010).
  • Skene PJ , IllingworthRS, WebbS et al. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol. Cell 37 , 457–468 (2010).
  • Kondo M , GrayLJ, PelkaGJ, ChristodoulouJ, TamPP, HannanAJ. Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome – Mecp2 gene dosage effects and BDNF expression. Eur. J. Neurosci.27 , 3342–3350 (2008).
  • Lonetti G , AngelucciA, MorandoL, BoggioEM, GiustettoM, PizzorussoT. Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice. Biol. Psychiatry67 , 657–665 (2010).
  • Nag N , MoriuchiJM, PeitzmanCG, WardBC, KolodnyNH, Berger-SweeneyJE. Environmental enrichment alters locomotor behaviour and ventricular volume in Mecp2 1lox mice. Behav. Brain Res.196 , 44–48 (2009).
  • Kerr B , SilvaPA, WalzK, YoungJI. Unconventional transcriptional response to environmental enrichment in a mouse model of Rett syndrome. PLoS One5 , e11534 (2010).
  • Burdge GC , LillycropKA, PhillipsES, Slater-JefferiesJL, JacksonAA, HansonMA. Folic acid supplementation during the juvenile-pubertal period in rats modifies the phenotype and epigenotype induced by prenatal nutrition. J. Nutr.139 , 1054–1060 (2009).
  • Rimland B . Controversies in the treatment of autistic children: vitamin and drug therapy. J. Child Neurol.3(Suppl.) , S68–S72 (1988).
  • James SJ , CutlerP, MelnykS et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr. 80 , 1611–1617 (2004).
  • Moretti P , SahooT, HylandK et al. Cerebral folate deficiency with developmental delay, autism, and response to folinic acid. Neurology 64 , 1088–1090 (2005).
  • Glaze DG , PercyAK, MotilKJ et al. A study of the treatment of Rett syndrome with folate and betaine. J. Child Neurol. 24 , 551–556 (2009).
  • Weaver IC , CervoniN, ChampagneFA et al. Epigenetic programming by maternal behavior. Nat. Neurosci. 7 , 847–854 (2004).
  • Lillycrop KA , PhillipsES, JacksonAA, HansonMA, BurdgeGC. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J. Nutr.135 , 382–386 (2005).
  • Kucharski R , MaleszkaJ, ForetS, MaleszkaR. Nutritional control of reproductive status in honeybees via DNA methylation. Science319 , 1827–1830 (2008).
  • Lillycrop KA , Slater-JefferiesJL, HansonMA, GodfreyKM, JacksonAA, BurdgeGC. Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications. Br. J. Nutr.97 , 1064–1073 (2007).
  • Tsankova NM , BertonO, RenthalW, KumarA, NeveRL, NestlerEJ. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci.9 , 519–525 (2006).
  • Jessberger S , NakashimaK, ClemensonGD Jr et al. Epigenetic modulation of seizure-induced neurogenesis and cognitive decline. J. Neurosci.27 , 5967–5975 (2007).
  • Dong E , NelsonM, GraysonDR, CostaE, GuidottiA. Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation. Proc. Natl Acad. Sci. USA105 , 13614–13619 (2008).
  • Ma DK , JangMH, GuoJU et al. Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis. Science 323 , 1074–1077 (2009).
  • Lim D , BowdinSC, TeeL. Clinical and molecular genetic features of Beckwith–Wiedemann syndrome associated with assisted reproductive technologies. Hum. Reprod.24 , 741–747 (2009).
  • Bliek J , AldersM, MaasSM et al. Lessons from BWS twins: complex maternal and paternal hypomethylation and a common source of haematopoietic stem cells. Eur. J. Hum. Genet. 17 , 1625–1634 (2009).
  • Fraga MF , BallestarE, PazMF et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl Acad. Sci. USA 102 , 10604–10609 (2005).
  • Miyake K , YangC, MinakuchiY et al. Genomic, epigenomic, expression comparison of monozygotic twins discordant for Rett syndrome. PLoS One 8 , e66729(2013).
  • Hotta A , CheungAY, FarraN et al. Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat. Methods 6 , 370–376 (2009).
  • Marchetto MC , CarromeuC, AcabA et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143 , 527–539 (2010).
  • Farra N , ZhangWB, PasceriP, EubanksJH, SalterMW, EllisJ. Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations. Mol. Psychiatry17 , 1261–1271 (2012).
  • Muotri AR , MarchettoMC, CoufalNG et al. L1 retrotransposition in neurons is modulated by MeCP2. Nature 468 , 443–446 (2010).
  • Luikenhuis S , GiacomettiE, BeardCF, JaenischR. Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc. Natl Acad. Sci. USA101 , 6033–6038 (2004).
  • Guy J , GanJ, SelfridgeJ, CobbS, BirdA. Reversal of neurological defects in a mouse model of Rett syndrome. Science315 , 1143–1147 (2007).
  • Cheung AY , HorvathLM, CarrelL, EllisJ. X-chromosome inactivation in Rett syndrome human induced pluripotent stem cells. Front. Psychiatry3 , 24(2012).
  • Tchieu J , KuoyE, ChinMH et al. Female human iPSCs retain an inactive X chromosome. Cell Stem Cell 7 , 329–342 (2010).
  • Ballas N , LioyDT, GrunseichC, MandelG. Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat. Neurosci.12 , 311–317 (2009).
  • Kishi N , MacklisJD. MeCP2 functions largely cell-autonomously, but also non-cell-autonomously, in neuronal maturation and dendritic arborization of cortical pyramidal neurons. Exp. Neurol.222 , 51–58 (2010).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.